← Back to Search

PPE and Air Hygiene for Flu Prevention (EMIT-2 Trial)

N/A
Recruiting
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Males and non-pregnant, non-breastfeeding females aged ≥18 and ≤49 years of age, at time of initial consent.
Within the past 72 hours at time of entry into the exposure event, onset of influenza-like illness, as defined as fever of ≥100.2°F AND cough or sore throat, in the absence of an alternative cause.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

EMIT-2 Trial Summary

This trial aims to find ways to reduce the spread of flu by limiting airborne transmission. #publichealth #flu

Who is the study for?
This trial is for healthy adults aged 18-49 who have recently contracted the flu. Participants must understand the study, stay in a research unit for about 5 days, and attend follow-ups. Pregnant or breastfeeding women, smokers, those with severe allergies to medicines, immunosuppressed individuals or those on certain medications cannot join.Check my eligibility
What is being tested?
The EMIT-2 trial is testing how well Personal Protective Equipment (PPE) works under different air hygiene conditions to prevent airborne transmission of influenza. People will be randomly assigned to either use PPE or not under low and high air cleanliness settings.See study design
What are the potential side effects?
Since this trial involves using PPE rather than medication, there are no direct side effects from drugs being tested. However, participants may experience discomfort or other issues related to wearing PPE such as skin irritation or difficulty breathing.

EMIT-2 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 49 years old, not pregnant, and not breastfeeding.
Select...
I've had a fever over 100.2°F and a cough or sore throat in the last 3 days without another known cause.
Select...
I agree to the study's terms and can stay in quarantine for about 5 days.
Select...
I don't have any undiagnosed or untreated ongoing health issues.

EMIT-2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Serological Confirmation
Symptomatic Confirmation
Viral Confirmation

EMIT-2 Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Intervention RecipientsExperimental Treatment2 Interventions
Intervention recipients are participants who do not have influenza and will use personal protective equipment.
Group II: DonorsExperimental Treatment2 Interventions
Donors are persons naturally infected with influenza.
Group III: Control RecipientsActive Control1 Intervention
Control recipients are participants who do not have influenza and will not be using personal protective equipment.

Find a Location

Who is running the clinical trial?

University of Maryland, BaltimoreLead Sponsor
685 Previous Clinical Trials
372,846 Total Patients Enrolled
University of Maryland, College ParkOTHER
154 Previous Clinical Trials
45,285 Total Patients Enrolled

Media Library

Influenza Research Study Groups: Control Recipients, Intervention Recipients, Donors

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the qualifications to join this medical experiment?

"To qualify for this trial, enrollees must have a confirmed case of the flu and be in between 18-49 years old. This clinical study is seeking to recruit 200 individuals."

Answered by AI

Is it permissible for individuals over the age of 55 to take part in this experiment?

"The entry requirements of this trial specify that participants must be aged 18 to 49. Additionally, there are 44 trials specifically tailored for those under the age of 18 and 81 studies available to people over 65 years old."

Answered by AI

Are there any open slots for enrollment in this clinical trial?

"From the data hosted by clinicaltrials.gov, it appears that this trial is not currently open for enrollment; its inception was on January 1st 2023 and the most recent edit was December 16th 2022. Despite their inactivity, there are 129 other trials actively enrolling patients at present."

Answered by AI
~133 spots leftby Jan 2028